Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3819100
Max Phase: Preclinical
Molecular Formula: C38H36ClNO13S3
Molecular Weight: 809.89
Molecule Type: Small molecule
Associated Items:
ID: ALA3819100
Max Phase: Preclinical
Molecular Formula: C38H36ClNO13S3
Molecular Weight: 809.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)COc1ccc(-c2cc(=S)ss2)cc1)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl
Standard InChI: InChI=1S/C38H35NO13S3.ClH/c1-16-33(42)21(39)10-27(51-16)52-23-13-38(47,25(40)14-50-26(41)15-49-18-8-6-17(7-9-18)24-11-28(53)55-54-24)12-20-30(23)37(46)32-31(35(20)44)34(43)19-4-3-5-22(48-2)29(19)36(32)45;/h3-9,11,16,21,23,27,33,42,44,46-47H,10,12-15,39H2,1-2H3;1H/t16-,21-,23-,27-,33+,38-;/m0./s1
Standard InChI Key: YOSGFJUSPGIYCP-QVUJIKCZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 809.89 | Molecular Weight (Monoisotopic): 809.1271 | AlogP: 4.15 | #Rotatable Bonds: 10 |
Polar Surface Area: 221.37 | Molecular Species: BASE | HBA: 17 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.00 | CX Basic pKa: 9.03 | CX LogP: 3.96 | CX LogD: 3.53 |
Aromatic Rings: 4 | Heavy Atoms: 55 | QED Weighted: 0.06 | Np Likeness Score: 0.94 |
1. Chegaev K, Rolando B, Cortese D, Gazzano E, Buondonno I, Lazzarato L, Fanelli M, Hattinger CM, Serra M, Riganti C, Fruttero R, Ghigo D, Gasco A.. (2016) H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance., 59 (10): [PMID:27120394] [10.1021/acs.jmedchem.6b00184] |
Source(1):